Open AccessEfficacy of icotinib versus traditional chemotherapy as first-line treatment for preventing brain metastasis from advanced lung adenocarcinoma in patients with epidermal growth factor receptor-sensitive mutation
Author(s) -
Fang Li,
Nan Du,
Xu Zhao,
Guangqin Zhu,
Huoming Chen,
Ping Yang
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.145851
Subject(s) - medicine , brain metastasis , oncology , adenocarcinoma , epidermal growth factor receptor , cumulative incidence , chemotherapy , metastasis , lung cancer , clinical endpoint , cancer , clinical trial , transplantation
This study aimed to investigate the potential use of icotinib as first-line treatment to prevent brain metastasis from advanced lung adenocarcinoma.